BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 17, 2013
View Archived Issues
Characterization of a small-molecule dual receptor inhibitor that targets oncogenic pathways
Read More
Ipsen aims to expand neurology R&D capabilities with acquisition of Syntaxin
Read More
First-in-human results presented for LY-2951742
Read More
Pluristem's PLX cells tested for treatment of radiation poisoning
Read More
Novel tyrosine-protein kinase inhibitors disclosed by Allergan
Read More
A novel adeno-associated virus gene therapy for mucopolysaccharidosis IIIA
Read More
AbbVie presents new TRPV1 antagonists for pain and other disorders
Read More
Merck & Co. synthesizes novel Hdm2 inhibitors
Read More
Biosortia and AstraZeneca enter drug discovery research agreement
Read More
Oryzon obtains European orphan drug designation for ORY-1001 in AML
Read More
OncoGenex completes patient enrollment in Borealis-1 trial in metastatic bladder cancer
Read More
Life Technologies and Merck Serono enter collaboration
Read More
FDA accepts Iroko's NDA for low-dose submicron indomethacin
Read More
Chinese group divulges novel FLT3 inhibitors
Read More
Toyama Chemical presents phase II results for T-817MA
Read More
Advanomics receives research grant to advance lead anticancer candidate
Read More
New protein kinase and apoptosis inducers reported by Bayer
Read More
Updated xTAG CYP2D6 Kit receives FDA and European clearance
Read More
Medivir describes new agents for HCV infection
Read More
Sequella obtains exclusive worldwide license to TB treatment candidate from Pfizer
Read More
Abide Therapeutics and UC San Diego receive grant to validate MAGL target
Read More
New mouse model of CD30-positive T-cell lymphoma described
Read More
Qualigen obtains 510(k) clearance from FDA for FastPack Vitamin D Immunoassay
Read More
Paladin Labs becomes sole shareholder of Allon Therapeutics
Read More
Basilea provides update on phase III program for isavuconazole
Read More
